154 related articles for article (PubMed ID: 3763677)
1. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021.
Baranes J; Hellegouarch A; Le Hegarat M; Viossat I; Auguet M; Chabrier PE; Braquet P
Pharmacol Res Commun; 1986 Aug; 18(8):717-37. PubMed ID: 3763677
[TBL] [Abstract][Full Text] [Related]
2. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs.
Koltai M; Lepran I; Szekeres L; Viossat I; Chabrier E; Braquet P
Eur J Pharmacol; 1986 Oct; 130(1-2):133-6. PubMed ID: 3780855
[TBL] [Abstract][Full Text] [Related]
3. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.
Sánchez-Crespo M; Fernández-Gallardo S; Nieto ML; Baranès J; Braquet P
Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779
[TBL] [Abstract][Full Text] [Related]
5. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
6. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.
Etienne A; Hecquet F; Soulard C; Spinnewyn B; Clostre F; Braquet P
Agents Actions; 1986 Jan; 17(3-4):368-70. PubMed ID: 3515870
[TBL] [Abstract][Full Text] [Related]
7. Effects of BN 52063 and other agents inhibiting platelet-activating factor-induced contractile responses in rat portal vein.
Hellegouarch A; Auguet M; Clostre F; Braquet P
J Pharm Pharmacol; 1988 Aug; 40(8):589-91. PubMed ID: 2907020
[TBL] [Abstract][Full Text] [Related]
8. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
Berti F; Omini C; Rossoni G; Braquet P
Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
Touvay C; Etienne A; Braquet P
Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380
[TBL] [Abstract][Full Text] [Related]
10. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.
Lagente V; Touvay C; Randon J; Desquand S; Cirino M; Vilain B; Lefort J; Braquet P; Vargaftig BB
Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
[TBL] [Abstract][Full Text] [Related]
12. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig.
Adnot S; Lefort J; Braquet P; Vargaftig BB
Prostaglandins; 1986 Dec; 32(6):791-802. PubMed ID: 3562865
[TBL] [Abstract][Full Text] [Related]
13. Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists.
Touvay C; Vilain B; Etienne A; Sirois P; Borgeat P; Braquet P
Immunopharmacology; 1986 Oct; 12(2):97-104. PubMed ID: 3021651
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
16. Evidence of a role for PAF-acether in the pathophysiology of the shock state.
Sanchez Crespo M; Inarrea P; Nieto ML; Fernandez-Gallardo S
Pharmacol Res Commun; 1986 Aug; 18 Suppl():181-96. PubMed ID: 3774844
[TBL] [Abstract][Full Text] [Related]
17. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
[TBL] [Abstract][Full Text] [Related]
18. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021.
Touvay C; Vilain B; Taylor JE; Etienne A; Braquet P
Prog Lipid Res; 1986; 25(1-4):277-88. PubMed ID: 2827186
[No Abstract] [Full Text] [Related]
19. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
Vilain B; Lagente V; Touvay C; Desquand S; Randon J; Lefort J; Braquet P; Vargaftig BB
Pharmacol Res Commun; 1986 Aug; 18 Suppl():119-26. PubMed ID: 3774840
[TBL] [Abstract][Full Text] [Related]
20. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig.
Bourgain RH; Maes L; Andries R; Braquet P
Prostaglandins; 1986 Jul; 32(1):142-4. PubMed ID: 3763943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
